Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 156 entries
Sorted by: Best Match Show Resources per page
Adjustment trajectories in college science programs: Perceptions of qualities of parents' and college teachers' relationships

science curriculum

Duchesne S, Larose S, Ratelle CF.
GSID: bO14cGFOXXoJ
S Duchesne, CF Ratelle, S Larose… - Journal of Counseling …, 2007 - psycnet.apa.org

This longitudinal study had 2 goals. The 1st goal was to describe trajectories of academic and emotional adjustment in college science programs. The 2nd goal was to determine …

Cite
Duchesne, S., Ratelle, C. F., Larose, S., & Guay, F. (2007). Adjustment trajectories in college science programs: Perceptions of qualities of parents' and college teachers' relationships. Journal of Counseling Psychology, 54(1), 62.
Duchesne, Stéphane, et al. "Adjustment trajectories in college science programs: Perceptions of qualities of parents' and college teachers' relationships." Journal of Counseling Psychology 54.1 (2007): 62.
Copy Download .nbib Format: MLA
Trajectories of anxiety during elementary-school years and the prediction of high school noncompletion

high school

Duchesne S, Vitaro F, Larose S.
GSID: BpbCfwXz5EkJ
S Duchesne, F Vitaro, S Larose… - Journal of youth and …, 2008 - Springer

… In the current study, we explored the developmental trajectories of anxiety during elementary school and examined how these trajectories affect high school noncompletion while controlling for sociofamily adversity, children’s behavioral characteristics and academic …

Cite
Duchesne, S., Vitaro, F., Larose, S., & Tremblay, R. E. (2008). Trajectories of anxiety during elementary-school years and the prediction of high school noncompletion. Journal of youth and adolescence, 37(9), 1134-1146.
Duchesne, Stéphane, et al. "Trajectories of anxiety during elementary-school years and the prediction of high school noncompletion." Journal of youth and adolescence 37.9 (2008): 1134-1146.
Copy Download .nbib Format: MLA
Aboveground carbon in Quebec forests: stock quantification at the provincial scale and assessment of temperature, precipitation and edaphic properties effects on the potential stand-level stocking.

PeerJ

Duchesne L, Houle D, Ouimet R, Lambert MC, Logan T.
PMID: 26966680
PeerJ. 2016 Mar 03;4:e1767. doi: 10.7717/peerj.1767. eCollection 2016.

Biological carbon sequestration by forest ecosystems plays an important role in the net balance of greenhouse gases, acting as a carbon sink for anthropogenic CO2 emissions. Nevertheless, relatively little is known about the abiotic environmental factors (including climate) that...

Cite
Duchesne L, Houle D, Ouimet R, et al. Aboveground carbon in Quebec forests: stock quantification at the provincial scale and assessment of temperature, precipitation and edaphic properties effects on the potential stand-level stocking. PeerJ. 2016;4:e1767doi: 10.7717/peerj.1767.
Duchesne, L., Houle, D., Ouimet, R., Lambert, M. C., & Logan, T. (2016). Aboveground carbon in Quebec forests: stock quantification at the provincial scale and assessment of temperature, precipitation and edaphic properties effects on the potential stand-level stocking. PeerJ, 4e1767. https://doi.org/10.7717/peerj.1767
Duchesne, Louis, et al. "Aboveground carbon in Quebec forests: stock quantification at the provincial scale and assessment of temperature, precipitation and edaphic properties effects on the potential stand-level stocking." PeerJ vol. 4 (2016): e1767. doi: https://doi.org/10.7717/peerj.1767
Duchesne L, Houle D, Ouimet R, Lambert MC, Logan T. Aboveground carbon in Quebec forests: stock quantification at the provincial scale and assessment of temperature, precipitation and edaphic properties effects on the potential stand-level stocking. PeerJ. 2016 Mar 03;4:e1767. doi: 10.7717/peerj.1767. eCollection 2016. PMID: 26966680; PMCID: PMC4782708.
Copy Download .nbib Format: NLM
The formation of ordered nanoclusters controls cadherin anchoring to actin and cell-cell contact fluidity.

The Journal of cell biology

Strale PO, Duchesne L, Peyret G, Montel L, Nguyen T, Png E, Tampé R, Troyanovsky S, Hénon S, Ladoux B, Mège RM.
PMID: 26370504
J Cell Biol. 2015 Sep 14;210(6):1033. doi: 10.1083/jcb.20141011109022015c.

No abstract available.

Cite
Strale PO, Duchesne L, Peyret G, et al. The formation of ordered nanoclusters controls cadherin anchoring to actin and cell-cell contact fluidity. J Cell Biol. 2015;210(6):1033doi: 10.1083/jcb.20141011109022015c.
Strale, P. O., Duchesne, L., Peyret, G., Montel, L., Nguyen, T., Png, E., Tampé, R., Troyanovsky, S., Hénon, S., Ladoux, B., & Mège, R. M. (2015). The formation of ordered nanoclusters controls cadherin anchoring to actin and cell-cell contact fluidity. The Journal of cell biology, 210(6), 1033. https://doi.org/10.1083/jcb.20141011109022015c
Strale, Pierre-Olivier, et al. "The formation of ordered nanoclusters controls cadherin anchoring to actin and cell-cell contact fluidity." The Journal of cell biology vol. 210,6 (2015): 1033. doi: https://doi.org/10.1083/jcb.20141011109022015c
Strale PO, Duchesne L, Peyret G, Montel L, Nguyen T, Png E, Tampé R, Troyanovsky S, Hénon S, Ladoux B, Mège RM. The formation of ordered nanoclusters controls cadherin anchoring to actin and cell-cell contact fluidity. J Cell Biol. 2015 Sep 14;210(6):1033. doi: 10.1083/jcb.20141011109022015c. PMID: 26370504; PMCID: PMC4576855.
Copy Download .nbib Format: NLM
Support for the use of objective comorbidity indices in the assessment of noncancer death risk in prostate cancer patients.

Prostate international

Ng SP, Duchesne G, Tai KH, Foroudi F, Kothari G, Williams S.
PMID: 28352617
Prostate Int. 2017 Mar;5(1):8-12. doi: 10.1016/j.prnil.2016.12.001. Epub 2016 Dec 18.

BACKGROUND: Prostate cancer management involves a balance between the risks of cancer death against those from other causes. To evaluate the performance of several comorbidity indices in predicting comorbid death in a prostate cancer radiotherapy cohort.METHODS: 2,131 men with...

Cite
Ng SP, Duchesne G, Tai KH, et al. Support for the use of objective comorbidity indices in the assessment of noncancer death risk in prostate cancer patients. Prostate Int. 2016;5(1):8-12doi: 10.1016/j.prnil.2016.12.001.
Ng, S. P., Duchesne, G., Tai, K. H., Foroudi, F., Kothari, G., & Williams, S. (2017). Support for the use of objective comorbidity indices in the assessment of noncancer death risk in prostate cancer patients. Prostate international, 5(1), 8-12. https://doi.org/10.1016/j.prnil.2016.12.001
Ng, Sweet Ping, et al. "Support for the use of objective comorbidity indices in the assessment of noncancer death risk in prostate cancer patients." Prostate international vol. 5,1 (2017): 8-12. doi: https://doi.org/10.1016/j.prnil.2016.12.001
Ng SP, Duchesne G, Tai KH, Foroudi F, Kothari G, Williams S. Support for the use of objective comorbidity indices in the assessment of noncancer death risk in prostate cancer patients. Prostate Int. 2017 Mar;5(1):8-12. doi: 10.1016/j.prnil.2016.12.001. Epub 2016 Dec 18. PMID: 28352617; PMCID: PMC5357856.
Copy Download .nbib Format: NLM
Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies.

Current oncology (Toronto, Ont.)

Gagnon J, Lévesque E, Borduas F, Chiquette J, Diorio C, Duchesne N, Dumais M, Eloy L, Foulkes W, Gervais N, Lalonde L, L'Espérance B, Meterissian S, Provencher L, Richard J, Savard C, Trop I, Wong N, Knoppers BM, Simard J.
PMID: 28050152
Curr Oncol. 2016 Dec;23(6):e615-e625. doi: 10.3747/co.23.2961. Epub 2016 Dec 21.

In recent years, risk stratification has sparked interest as an innovative approach to disease screening and prevention. The approach effectively personalizes individual risk, opening the way to screening and prevention interventions that are adapted to subpopulations. The international perspective...

Cite
Gagnon J, Lévesque E, et al. Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies. Curr Oncol. 2016;23(6):e615-e625doi: 10.3747/co.23.2961.
Gagnon, J., Lévesque, E., Borduas, F., Chiquette, J., Diorio, C., Duchesne, N., Dumais, M., Eloy, L., Foulkes, W., Gervais, N., Lalonde, L., L'Espérance, B., Meterissian, S., Provencher, L., Richard, J., Savard, C., Trop, I., Wong, N., Knoppers, B. M., & Simard, J. (2016). Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies. Current oncology (Toronto, Ont.), 23(6), e615-e625. https://doi.org/10.3747/co.23.2961
Gagnon, J, et al. "Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies." Current oncology (Toronto, Ont.) vol. 23,6 (2016): e615-e625. doi: https://doi.org/10.3747/co.23.2961
Gagnon J, Lévesque E, Borduas F, Chiquette J, Diorio C, Duchesne N, Dumais M, Eloy L, Foulkes W, Gervais N, Lalonde L, L'Espérance B, Meterissian S, Provencher L, Richard J, Savard C, Trop I, Wong N, Knoppers BM, Simard J. Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies. Curr Oncol. 2016 Dec;23(6):e615-e625. doi: 10.3747/co.23.2961. Epub 2016 Dec 21. PMID: 28050152; PMCID: PMC5176389.
Copy Download .nbib Format: NLM
Test-retest reliability of a new medial temporal atrophy morphological metric.

International journal of Alzheimer's disease

Duchesne S, Valdivia F, Mouiha A, Robitaille N.
PMID: 23024883
Int J Alzheimers Dis. 2012;2012:979804. doi: 10.1155/2012/979804. Epub 2012 Sep 17.

Clinicians and researchers alike are in need of quantitative and robust measurement tools to assess medial temporal lobe atrophy (MTA) due to Alzheimer's disease (AD). We recently proposed a morphological metric, extracted from T1-weighted magnetic resonance images (MRI), to...

Cite
Duchesne S, Valdivia F, Mouiha A, et al. Test-retest reliability of a new medial temporal atrophy morphological metric. Int J Alzheimers Dis. 2012;2012:979804doi: 10.1155/2012/979804.
Duchesne, S., Valdivia, F., Mouiha, A., & Robitaille, N. (2012). Test-retest reliability of a new medial temporal atrophy morphological metric. International journal of Alzheimer's disease, 2012979804. https://doi.org/10.1155/2012/979804
Duchesne, Simon, et al. "Test-retest reliability of a new medial temporal atrophy morphological metric." International journal of Alzheimer's disease vol. 2012 (2012): 979804. doi: https://doi.org/10.1155/2012/979804
Duchesne S, Valdivia F, Mouiha A, Robitaille N. Test-retest reliability of a new medial temporal atrophy morphological metric. Int J Alzheimers Dis. 2012;2012:979804. doi: 10.1155/2012/979804. Epub 2012 Sep 17. PMID: 23024883; PMCID: PMC3457661.
Copy Download .nbib Format: NLM
Mixed Treatment Comparisons to Compare Simeprevir with Boceprevir and Telaprevir in Combination with Peg-Interferon Alpha and Ribavirin (Pr) in Patients Infected with Genotype 1 Hepatitis C Virus (Hcv).

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Taieb V, Pacou M, Van Sanden S, Sbarigia U, Mehnert A, Duchesne I.
PMID: 27202427
Value Health. 2014 Nov;17(7):A665. doi: 10.1016/j.jval.2014.08.2450. Epub 2014 Oct 26.

No abstract available.

Cite
Taieb V, Pacou M, Van Sanden S, et al. Mixed Treatment Comparisons to Compare Simeprevir with Boceprevir and Telaprevir in Combination with Peg-Interferon Alpha and Ribavirin (Pr) in Patients Infected with Genotype 1 Hepatitis C Virus (Hcv). Value Health. 2014;17(7):A665doi: 10.1016/j.jval.2014.08.2450.
Taieb, V., Pacou, M., Van Sanden, S., Sbarigia, U., Mehnert, A., & Duchesne, I. (2014). Mixed Treatment Comparisons to Compare Simeprevir with Boceprevir and Telaprevir in Combination with Peg-Interferon Alpha and Ribavirin (Pr) in Patients Infected with Genotype 1 Hepatitis C Virus (Hcv). Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A665. https://doi.org/10.1016/j.jval.2014.08.2450
Taieb, V, et al. "Mixed Treatment Comparisons to Compare Simeprevir with Boceprevir and Telaprevir in Combination with Peg-Interferon Alpha and Ribavirin (Pr) in Patients Infected with Genotype 1 Hepatitis C Virus (Hcv)." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A665. doi: https://doi.org/10.1016/j.jval.2014.08.2450
Taieb V, Pacou M, Van Sanden S, Sbarigia U, Mehnert A, Duchesne I. Mixed Treatment Comparisons to Compare Simeprevir with Boceprevir and Telaprevir in Combination with Peg-Interferon Alpha and Ribavirin (Pr) in Patients Infected with Genotype 1 Hepatitis C Virus (Hcv). Value Health. 2014 Nov;17(7):A665. doi: 10.1016/j.jval.2014.08.2450. Epub 2014 Oct 26. PMID: 27202427.
Copy Download .nbib Format: NLM
Photothermal Catalyst Engineering: Hydrogenation of Gaseous CO.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Jia J, Wang H, Lu Z, O'Brien PG, Ghoussoub M, Duchesne P, Zheng Z, Li P, Qiao Q, Wang L, Gu A, Jelle AA, Dong Y, Wang Q, Ghuman KK, Wood T, Qian C, Shao Y, Qiu C, Ye M, Zhu Y, Lu ZH, Zhang P, Helmy AS, Singh CV, Kherani NP, Perovic DD, Ozin GA.
PMID: 29051865
Adv Sci (Weinh). 2017 Jul 25;4(10):1700252. doi: 10.1002/advs.201700252. eCollection 2017 Oct.

This study has designed and implemented a library of hetero-nanostructured catalysts, denoted as Pd@Nb

Cite
Jia J, Wang H, Lu Z, et al. Photothermal Catalyst Engineering: Hydrogenation of Gaseous CO. Adv Sci (Weinh). 2017;4(10):1700252doi: 10.1002/advs.201700252.
Jia, J., Wang, H., Lu, Z., O'Brien, P. G., Ghoussoub, M., Duchesne, P., Zheng, Z., Li, P., Qiao, Q., Wang, L., Gu, A., Jelle, A. A., Dong, Y., Wang, Q., Ghuman, K. K., Wood, T., Qian, C., Shao, Y., Qiu, C., Ye, M., Zhu, Y., Lu, Z. H., Zhang, P., Helmy, A. S., Singh, C. V., Kherani, N. P., Perovic, D. D., & Ozin, G. A. (2017). Photothermal Catalyst Engineering: Hydrogenation of Gaseous CO. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 4(10), 1700252. https://doi.org/10.1002/advs.201700252
Jia, Jia, et al. "Photothermal Catalyst Engineering: Hydrogenation of Gaseous CO." Advanced science (Weinheim, Baden-Wurttemberg, Germany) vol. 4,10 (2017): 1700252. doi: https://doi.org/10.1002/advs.201700252
Jia J, Wang H, Lu Z, O'Brien PG, Ghoussoub M, Duchesne P, Zheng Z, Li P, Qiao Q, Wang L, Gu A, Jelle AA, Dong Y, Wang Q, Ghuman KK, Wood T, Qian C, Shao Y, Qiu C, Ye M, Zhu Y, Lu ZH, Zhang P, Helmy AS, Singh CV, Kherani NP, Perovic DD, Ozin GA. Photothermal Catalyst Engineering: Hydrogenation of Gaseous CO. Adv Sci (Weinh). 2017 Jul 25;4(10):1700252. doi: 10.1002/advs.201700252. eCollection 2017 Oct. PMID: 29051865; PMCID: PMC5644230.
Copy Download .nbib Format: NLM
Impact of STAT3 phosphorylation in glioblastoma stem cells radiosensitization and patient outcome.

Oncotarget

Masliantsev K, Pinel B, Balbous A, Guichet PO, Tachon G, Milin S, Godet J, Duchesne M, Berger A, Petropoulos C, Wager M, Karayan-Tapon L.
PMID: 29423098
Oncotarget. 2017 Dec 16;9(3):3968-3979. doi: 10.18632/oncotarget.23374. eCollection 2018 Jan 09.

Glioblastoma (GBM) represents the most common and lethal primary malignant brain tumor. The standard treatment for glioblastoma patients involves surgical resection with concomitant radio and chemotherapy. Despite today's clinical protocol, the prognosis for patients remains very poor with a...

Cite
Masliantsev K, Pinel B, Balbous A, et al. Impact of STAT3 phosphorylation in glioblastoma stem cells radiosensitization and patient outcome. Oncotarget. 2017;9(3):3968-3979doi: 10.18632/oncotarget.23374.
Masliantsev, K., Pinel, B., Balbous, A., Guichet, P. O., Tachon, G., Milin, S., Godet, J., Duchesne, M., Berger, A., Petropoulos, C., Wager, M., & Karayan-Tapon, L. (2018). Impact of STAT3 phosphorylation in glioblastoma stem cells radiosensitization and patient outcome. Oncotarget, 9(3), 3968-3979. https://doi.org/10.18632/oncotarget.23374
Masliantsev, Konstantin, et al. "Impact of STAT3 phosphorylation in glioblastoma stem cells radiosensitization and patient outcome." Oncotarget vol. 9,3 (2018): 3968-3979. doi: https://doi.org/10.18632/oncotarget.23374
Masliantsev K, Pinel B, Balbous A, Guichet PO, Tachon G, Milin S, Godet J, Duchesne M, Berger A, Petropoulos C, Wager M, Karayan-Tapon L. Impact of STAT3 phosphorylation in glioblastoma stem cells radiosensitization and patient outcome. Oncotarget. 2017 Dec 16;9(3):3968-3979. doi: 10.18632/oncotarget.23374. eCollection 2018 Jan 09. PMID: 29423098; PMCID: PMC5790515.
Copy Download .nbib Format: NLM
Source Separation Using Sensor's Frequency Response: Theory and Practice on Carbon Nanotubes Sensors.

Sensors (Basel, Switzerland)

Quelennec A, Duchesne É, Frémont H, Drouin D.
PMID: 31382380
Sensors (Basel). 2019 Aug 02;19(15). doi: 10.3390/s19153389.

Nowadays, there is an increased demand in integrated sensors for electronic devices. Multi-functional sensors provide the same amount of data using fewer sensors. Carbon nanotubes are non-selectively sensitive to temperature, gas and strain. Thus, carbon nanotubes are perfect candidates...

Cite
Quelennec A, Duchesne É, Frémont H, et al. Source Separation Using Sensor's Frequency Response: Theory and Practice on Carbon Nanotubes Sensors. Sensors (Basel). 2019;19(15)doi: 10.3390/s19153389.
Quelennec, A., Duchesne, �. �., Frémont, H., & Drouin, D. (2019). Source Separation Using Sensor's Frequency Response: Theory and Practice on Carbon Nanotubes Sensors. Sensors (Basel, Switzerland), 19(15), . https://doi.org/10.3390/s19153389
Quelennec, Aurore, et al. "Source Separation Using Sensor's Frequency Response: Theory and Practice on Carbon Nanotubes Sensors." Sensors (Basel, Switzerland) vol. 19,15 (2019). doi: https://doi.org/10.3390/s19153389
Quelennec A, Duchesne É, Frémont H, Drouin D. Source Separation Using Sensor's Frequency Response: Theory and Practice on Carbon Nanotubes Sensors. Sensors (Basel). 2019 Aug 02;19(15). doi: 10.3390/s19153389. PMID: 31382380; PMCID: PMC6696222.
Copy Download .nbib Format: NLM
Optimizing choice of oral interferon-free treatment for genotype 1 hepatitis C virus using testing for NS5A resistance: a cost-utility analysis from the perspective of the Italian National Health Service.

ClinicoEconomics and outcomes research : CEOR

Westerhout KY, Bouwmeester W, Duchesne I, Pisini M, Piena MA, Damele F, Gueron B, Treur M, Belsey J.
PMID: 28280374
Clinicoecon Outcomes Res. 2017 Feb 27;9:163-172. doi: 10.2147/CEOR.S117650. eCollection 2017.

BACKGROUND: Patients with genotype-1 hepatitis C virus infection who have failed to respond to standard therapy or who relapse following treatment may be considered for an interferon-free regimen incorporating a nonstructural protein 5A (NS5A) inhibitor. Sustained virologic response (SVR)...

Cite
Westerhout KY, Bouwmeester W, Duchesne I, et al. Optimizing choice of oral interferon-free treatment for genotype 1 hepatitis C virus using testing for NS5A resistance: a cost-utility analysis from the perspective of the Italian National Health Service. Clinicoecon Outcomes Res. 2017;9:163-172doi: 10.2147/CEOR.S117650.
Westerhout, K. Y., Bouwmeester, W., Duchesne, I., Pisini, M., Piena, M. A., Damele, F., Gueron, B., Treur, M., & Belsey, J. (2017). Optimizing choice of oral interferon-free treatment for genotype 1 hepatitis C virus using testing for NS5A resistance: a cost-utility analysis from the perspective of the Italian National Health Service. ClinicoEconomics and outcomes research : CEOR, 9163-172. https://doi.org/10.2147/CEOR.S117650
Westerhout, Kirsten Y, et al. "Optimizing choice of oral interferon-free treatment for genotype 1 hepatitis C virus using testing for NS5A resistance: a cost-utility analysis from the perspective of the Italian National Health Service." ClinicoEconomics and outcomes research : CEOR vol. 9 (2017): 163-172. doi: https://doi.org/10.2147/CEOR.S117650
Westerhout KY, Bouwmeester W, Duchesne I, Pisini M, Piena MA, Damele F, Gueron B, Treur M, Belsey J. Optimizing choice of oral interferon-free treatment for genotype 1 hepatitis C virus using testing for NS5A resistance: a cost-utility analysis from the perspective of the Italian National Health Service. Clinicoecon Outcomes Res. 2017 Feb 27;9:163-172. doi: 10.2147/CEOR.S117650. eCollection 2017. PMID: 28280374; PMCID: PMC5338846.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 156 entries